Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05COQ
|
||||
| Former ID |
DNC006695
|
||||
| Drug Name |
H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2
|
||||
| Indication | Discovery agent | Investigative | [528320] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C49H65N11O10S2
|
||||
| Canonical SMILES |
CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCC<br />N)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)<br />N)C(=O)NC(C(C)O)C(=O)N)O
|
||||
| InChI |
1S/C49H65N11O10S2/c1-27(61)40(42(52)63)59-48(69)39-26-72-71-25-38(57-43(64)33(51)21-29-13-5-3-6-14-29)47(68)55-36(22-30-15-7-4-8-16-30)45(66)56-37(23-31-24-53-34-18-10-9-17-32(31)34)46(67)54-35(19-11-12-20-50)44(65)60-41(28(2)62)49(70)58-39/h3-10,13-18,24,27-28,33,35-41,53,61-62H,11-12,19-23,25-26,50-51H2,1-2H3,(H2,52,63)(H,54,67)(H,55,68)(H,56,66)(H,57,64)(H,58,70)(H,59,69)(H,60,65)/t27-,28-,33-,35+,36+,37-,38+,39+,40+,41+/m1/s1
|
||||
| InChIKey |
SGYDRBBPYPDBRO-WNIOSIORSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Somatostatin receptor type 2 | Target Info | Inhibitor | [528320] | |
| Somatostatin receptor type 5 | Target Info | Inhibitor | [528320] | ||
| Somatostatin receptor type 3 | Target Info | Inhibitor | [528320] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.